Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

MINARDI, Viviana Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.704
EU - Europa 928
AS - Asia 674
SA - Sud America 163
Continente sconosciuto - Info sul continente non disponibili 55
AF - Africa 37
OC - Oceania 2
Totale 3.563
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.671
RU - Federazione Russa 252
SG - Singapore 227
CN - Cina 195
DE - Germania 134
IT - Italia 123
BR - Brasile 117
FI - Finlandia 99
UA - Ucraina 85
HK - Hong Kong 66
GB - Regno Unito 50
VN - Vietnam 49
IE - Irlanda 43
SE - Svezia 41
PL - Polonia 37
FR - Francia 27
IN - India 26
JP - Giappone 23
BD - Bangladesh 21
CA - Canada 19
CI - Costa d'Avorio 16
KR - Corea 16
VE - Venezuela 12
AR - Argentina 11
EC - Ecuador 8
IQ - Iraq 8
CO - Colombia 7
MX - Messico 7
TR - Turchia 7
UZ - Uzbekistan 7
AT - Austria 5
ES - Italia 5
GR - Grecia 5
EG - Egitto 4
ID - Indonesia 4
MA - Marocco 4
NL - Olanda 4
PK - Pakistan 4
RS - Serbia 4
CL - Cile 3
OM - Oman 3
PY - Paraguay 3
ZA - Sudafrica 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
CG - Congo 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
IR - Iran 2
JM - Giamaica 2
KE - Kenya 2
LB - Libano 2
LT - Lituania 2
UY - Uruguay 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BE - Belgio 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CH - Svizzera 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GE - Georgia 1
HN - Honduras 1
HU - Ungheria 1
KH - Cambogia 1
KZ - Kazakistan 1
LY - Libia 1
MC - Monaco 1
MD - Moldavia 1
MM - Myanmar 1
MN - Mongolia 1
MY - Malesia 1
NG - Nigeria 1
PH - Filippine 1
QA - Qatar 1
RO - Romania 1
SA - Arabia Saudita 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.509
Salva come PNG Salva come JPEG
Città #
Ashburn 237
Singapore 149
Fairfield 138
San Jose 105
Chandler 91
Wilmington 80
Woodbridge 79
Hong Kong 66
Seattle 65
Houston 62
Cambridge 57
Jacksonville 46
Dublin 43
Des Moines 42
Moscow 42
Santa Clara 35
Zgierz 32
Nanjing 31
Beijing 29
Los Angeles 27
Ann Arbor 26
Medford 26
Frankfurt am Main 24
Boardman 23
Council Bluffs 22
Tokyo 22
Altamura 20
Hefei 20
Helsinki 20
Dearborn 18
Falls Church 18
New York 17
Abidjan 16
Chicago 16
Ho Chi Minh City 16
Princeton 16
Buffalo 14
Dallas 14
Hanoi 14
São Paulo 14
Lawrence 13
San Diego 12
Lauterbourg 11
Tulsa 11
London 9
Palermo 9
San Mateo 9
Hebei 8
Jinan 8
Orem 8
Kumar 7
Milan 7
Philadelphia 7
Ludwigshafen am Rhein 6
Napoli 6
Ningbo 6
Seongnam 6
Shenyang 6
The Dalles 6
Da Nang 5
Zhengzhou 5
Belo Horizonte 4
Brasília 4
Changsha 4
Clifton 4
Curitiba 4
Edinburgh 4
Miami 4
Munich 4
Phoenix 4
Poplar 4
Quito 4
San Paolo di Civitate 4
Tashkent 4
Tianjin 4
Toronto 4
Washington 4
Baghdad 3
Bogotá 3
Campinas 3
Chennai 3
City of London 3
Columbus 3
Dhaka 3
El Tigre 3
Guayaquil 3
Jiaxing 3
Madison 3
Mumbai 3
Muscat 3
Nanchang 3
Ribeirão Preto 3
Verona 3
Warsaw 3
Ankara 2
Aswān 2
Athens 2
Atlanta 2
Auburn Hills 2
Barcelona 2
Totale 2.124
Salva come PNG Salva come JPEG
Nome #
Splenic marginal zone lymphoma with or without villous lymphocytes 288
Assessment of the frequency of additional cancers in patients with splenic marginal zone lymphoma. 257
Assessment of the Frequency of Additional Malignancies in Patients with Splenic Marginal Zone Lymphoma 249
Pre-empitive treatment with ciclofovir for cytomegalovirus antigenemia in autologous bone marrow recipient and CLL patients on therapy with alentuzumab 248
Splenic marginal zone lymphoma: a prognostic model for clinical use. 246
Assessment of the Frequency of Additional Malignancies in Patients with Splenic Marginal Zone Lymphoma (SMZL) 239
Hepatitis B virus reactivation and alemtuzumab therapy 235
Angioimmunoblastic T-cell lymphoma 235
Use of intrapleural bortezomib in myelomatous pleural effusion [1] 217
Response-based chemotherapy and involved field radiation for intermediate stage Hodgkin disease. A GISL/NHLSG trial. 214
Deoxycoformycin (pentostatin) in the treatment of Splenic Marginal Zone Lymphoma (SMZL)with or without villous lymphocytes 205
Presenting features and outcome of Splenic Marginal Zone Lymphoma with or without villous lymphocytes. A retrospective analysis in a Series of 145 Patients 200
Response-guided ABVD chemotherapy plus involved-field radiation therapy for intermediate-stage hodgkin lymphoma in the pre-positron emission tomography era: A Gruppo Italiano Studio Linfomi (GISL) prospective trial 196
Deferment of objective assessment of deep vein thrombosis and pulmonary embolism without increased risk of thrombosis: a practical approach based on the pretest clinical model, D-dimer testing, and the use of low-molecular-weight heparins 192
Infezione occulta da HBV in pazienti con malattie oncoematologiche 172
Presenting features and prognostic factors in Splenic Marginal Zone Lymphoma. A study on 145 patients. 170
Totale 3.563
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.080
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.080
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022160 0 0 0 4 15 15 11 4 29 42 8 32
2022/2023260 19 55 2 22 27 52 29 19 23 1 10 1
2023/2024125 4 15 16 21 7 16 11 7 0 4 0 24
2024/2025355 22 21 7 25 20 11 39 25 19 37 49 80
2025/20261.284 132 35 64 82 99 195 144 133 81 213 49 57
2026/2027181 46 37 98 0 0 0 0 0 0 0 0 0
Totale 3.563